کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
2956181 | 1578025 | 2016 | 11 صفحه PDF | دانلود رایگان |
• Treatment-resistant hypertension is common among patients with hypertension treated in the primary care setting.
• Pharmacist/physician team-based care is more effective than usual primary care at reducing blood pressure in treatment-resistant hypertension.
• The benefits of team-based care may derive from more frequent follow-up, drug optimization, and improved adherence.
Team-based care has been recommended for patients with treatment-resistant hypertension (TRH), but its efficacy in this setting is unknown. We compared a physician-pharmacist collaborative model (PPCM) to usual care in patients with TRH participating in the Collaboration Among Pharmacists and Physicians To Improve Outcomes Now study. At baseline, 169 patients (27% of Collaboration Among Pharmacists and Physicians To Improve Outcomes Now patients) had TRH: 111 received the PPCM intervention and 58 received usual care. Baseline characteristics were similar between treatment arms. After 9 months, adjusted mean systolic blood pressure was reduced by 7 mm Hg more with PPCM intervention than usual care (P = .036). Blood pressure control was 34.2% with PPCM versus 25.9% with usual care (adjusted odds ratio, 1.92; 95% confidence interval, 0.33–11.2). These findings suggest that team-based care in the primary care setting may be effective for TRH. Additional research is needed regarding the long-term impact of these models and to identify patients most likely to benefit from team-based interventions.
Journal: Journal of the American Society of Hypertension - Volume 10, Issue 4, April 2016, Pages 307–317